Correlation Between Sartorius Stedim and SARTORIUS

Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and SARTORIUS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and SARTORIUS into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sartorius Stedim Biotech and SARTORIUS AG UNSPADR, you can compare the effects of market volatilities on Sartorius Stedim and SARTORIUS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of SARTORIUS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and SARTORIUS.

Diversification Opportunities for Sartorius Stedim and SARTORIUS

0.74

Correlation Coefficient

Sartorius Stedim  SARTORIUS

Poor diversification

The 3 months correlation between Sartorius and SARTORIUS is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and SARTORIUS AG UNSPADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SARTORIUS AG UNSPADR and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with SARTORIUS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SARTORIUS AG UNSPADR has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and SARTORIUS go up and down completely randomly.

Pair Corralation between Sartorius Stedim and SARTORIUS

Assuming the 90 days trading horizon Sartorius Stedim Biotech is expected to generate 1.03 times more return on investment than SARTORIUS. However, Sartorius Stedim is 1.03 times more volatile than SARTORIUS AG UNSPADR. It trades about -0.02 of its potential returns per unit of risk. SARTORIUS AG UNSPADR is currently generating about -0.03 per unit of risk. If you would invest  28,984  in Sartorius Stedim Biotech on September 24, 2024 and sell it today you would lose (10,654) from holding Sartorius Stedim Biotech or give up 36.76% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	99.8%
Values	Daily Returns

Sartorius Stedim Biotech  vs.  SARTORIUS AG UNSPADR

Sartorius Stedim Biotech

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Sartorius Stedim may actually be approaching a critical reversion point that can send shares even higher in January 2025.

SARTORIUS AG UNSPADR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SARTORIUS AG UNSPADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, SARTORIUS is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Sartorius Stedim and SARTORIUS

The main advantage of trading using opposite Sartorius Stedim and SARTORIUS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, SARTORIUS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SARTORIUS will offset losses from the drop in SARTORIUS's long position.

The idea behind Sartorius Stedim Biotech and SARTORIUS AG UNSPADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.